Answers are grounded in this paper and cite their sources.
Conspectus Atherosclerosis is a chronic vascular disease in which redox imbalance, protein modification, and metabolic remodeling can emerge before overt plaque morphology. Fluorescent probes translate these biochemical changes into spatially resolved optical signals and therefore complement structural vascular imaging. Importantly, the pathological meaning of these signals depends not on fluorescence intensity alone but on the disease stage, biological compartment, and molecular context in which they arise. In this Account, we examine how activatable fluorescence imaging is evolving from the detection of isolated biomarkers toward context-resolved analysis of atherosclerosis-associated molecular states. We highlight three complementary strategies for early molecular detection. Sequence-gated recognition captures coupled inflammatory-redox events, while multiparameter imaging places phosphorylation-associated changes within microenvironmental, redox, and metabolic contexts. Conformation-sensitive imaging provides a third complementary strategy by extending molecular analysis to perturbations in proteostasis. We further discuss how fluorescence imaging provides complementary mechanistic views of vascular redox injury, including protein thiol oxidation, foam-cell remodeling, oxidative lipid injury, and plaque remodeling. Because these observations derive from different probes and experimental models, they are interpreted as complementary mechanistic windows rather than as a single sequential disease pathway. Overall, the studies considered here emphasize that the pathological meaning of a fluorescence signal depends not only on what is detected but also on where, when, and in what biochemical context it arises.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: